Articles

Integrative prognostic models predict long-term survival after immunochemotherapy in chronic lymphocytic leukemia patients

Department of Internal Medicine III, University of Ulm, Ulm
Division of Biostatistics, German Cancer Research Center, Heidelberg
Genomics Core Facility, University of Ulm, Ulm
Genomics Core Facility, University of Ulm, Ulm
Department of Internal Medicine III, University of Ulm, Ulm
Department I for Internal Medicine and Centre for Integrated Oncology, University of Cologne, Cologne
Clinical Development Oncology, Roche Products Ltd, Welwyn Garden City
Department of Internal Medicine III, University of Ulm, Ulm
Department I for Internal Medicine and Centre for Integrated Oncology, University of Cologne, Cologne
Department of Internal Medicine III, University of Ulm, Ulm, Germany; German Cancer Research Center (DKFZ), Heidelberg
Department of Internal Medicine III, University of Ulm, Ulm
Department I for Internal Medicine and Centre for Integrated Oncology, University of Cologne, Cologne
Department I for Internal Medicine and Centre for Integrated Oncology, University of Cologne, Cologne
Department of Internal Medicine III, University of Ulm, Ulm
Division of Biostatistics, German Cancer Research Center, Heidelberg
Department of Internal Medicine III, University of Ulm, Ulm
Haematologica Early view Mar 18, 2021 https://doi.org/10.3324/haematol.2020.251561